GNPX Trade on Feb 25, 2020 10:14 from beno: Tradervue User Stock Trades.

Fundamentals

Shares Outstanding: 32.8m (latest)
Cash: 2.55m (+ $8m from Jan 28 offering, + $17.5m from Feb 19 offering)
Current liabilities: 537k
Current ratio: 6.72
NWC (total current assets - total current liabilities): 3.07m
Monthly Burn rate (net loss / months): 578k
Estimated current cash: 527k
Accumulated deficit: 38m
Book value (Stock holder equity / Shares outstanding): 0.223 (no longer accurate with new SO)

Catalysts / News / Painting the picture

-Receives FDA Fast track for its Oncorpex Immunogene therapy that targets lung cancer
-Sign Exclusive License Agreement with University of Pittsburgh for Potentially Curative Gene Therapy Candidate for Diabetes
-$25m shelf, recent offering 17/01/20 for $1.267m
-2020-01-28: Closes $8m offering
-2020-02-21: Closes $17.5m offering
-Enough cash for 43.5 months! Doesn't need to do another offering for awhile!

Technical Analysis

-Levels: 6, 6.50, 7
-Parabolic morning and faded all day

Original Plan / Strategy

First Test short of 6.60 level

Review

Only got one lot in before it failed, took 10 cents of profit on the one lot as SSR was on.